Reviews push pet food nutrition toward bioactive evidence

Version 2

Two recent review papers are helping define the next phase of pet nutrition: a shift from talking loosely about “functional ingredients” to asking which bioactive compounds actually do something meaningful in dogs and cats, at what dose, in what formulation, and with what level of evidence. The Veterinary Research Communications review by Guo, Farooq, and Liu frames functional ingredients in companion animal diets as a targeted strategy to support health and reduce disease risk, while the Animals review drills down on plant-derived ingredients, including polyphenols, extracts, microalgae, omega-3 sources, and cannabinoids. Together, they suggest the field is becoming more mechanistic and more clinically ambitious, even as the supporting evidence remains mixed. (sciencedirect.com)

That evolution has been building for years. Earlier literature in dogs and cats described functional foods as dietary components that may deliver benefits beyond basic nutrition, but also warned that many candidate ingredients were being discussed before strong species-specific validation was available. More recent veterinary nutrition commentary has continued in the same direction, highlighting microbiome modulation, inflammatory signaling, oxidative stress, and metabolic support as the main pathways through which these ingredients may act. In other words, the concept isn’t new, but the framing is getting more precise, and that matters as commercial pet food makers increasingly market diets around gut health, mobility, skin, cognition, calm behavior, and immune support. (sciencedirect.com)

The new reviews appear to organize a crowded category that has often lacked consistent terminology. Based on the source abstracts and related literature, the Veterinary Research Communications paper focuses on definitions and classification systems for functional ingredients, bioactive compounds, and supplements in pets, then connects those categories to mechanisms and clinical evidence. The Animals paper adds a phytochemical lens, classifying plant-derived ingredients by compound group and delivery form, and highlighting antioxidant, anti-inflammatory, immunomodulatory, microbiome-regulating, and lipid-metabolism effects. It also flags an important practical issue for clinicians and formulators alike: not all ingredients in a broad category behave the same way, and dose, matrix, processing, and bioavailability can change outcomes. That inference is consistent with broader animal nutrition literature showing that performance of phytogenics and other bioactives can vary with composition, diet form, and feeding context. (sciencedirect.com)

Regulatory guardrails remain a major part of the story. In the U.S., AAFCO states that ingredients used in pet food must be GRAS, approved food additives, or otherwise sanctioned for feed use, and it draws a clear line between acceptable nutrition-related claims and impermissible drug claims. Claims such as reducing inflammation or improving joint function can trigger drug concerns if they imply treatment rather than nutritive value. AAFCO also notes that label claims should be supported by substantiation, and recent FDA guidance has continued to recognize AAFCO-defined ingredients during the current transition in ingredient oversight. For companies developing functional diets, that means formulation innovation still has to fit within a tightly watched labeling and ingredient framework. (aafco.org)

Expert nutrition groups are also signaling caution. WSAVA’s Global Nutrition Committee positions the veterinary team as the evidence-based source of nutrition advice and emphasizes nutritional assessment at every visit, individualized recommendations, and selection of appropriate, well-formulated diets. Its consumer and clinical tools focus less on trendy ingredients and more on whether a manufacturer has nutritional expertise, quality control, and supporting research behind the product. That’s especially relevant now, because pet parents are hearing more about botanicals, prebiotics, postbiotics, algae-derived nutrients, and cannabinoids, while the clinical literature still varies widely in rigor, endpoint selection, and reproducibility. (wsava.org)

Why it matters: For veterinarians, these reviews are useful not because they settle the debate, but because they help separate plausible science from broad marketing language. The likely near-term impact is more nuanced client communication: explaining that some functional ingredients, such as omega-3 fatty acids, certain fibers, and some microbiome-directed ingredients, have a stronger footing than others, while many plant bioactives still need more canine- and feline-specific clinical validation. They also reinforce that the unit of care is still the whole diet and the patient in front of you, not a single headline ingredient. A complete and balanced food with strong formulation standards may matter more clinically than a longer list of wellness-forward additives. (petfoodindustry.com)

Another practical implication is that the gap between consumer-facing language and regulatory language may widen before it narrows. “Functional” is a compelling concept for pet parents, but the evidence needed to support a structure-function style message is not the same as the evidence needed to justify disease-related expectations. That creates risk for confusion in exam rooms, especially when supplements, treats, and complete diets all borrow similar language. Veterinary teams may increasingly need to ask not just what ingredient is present, but how much is present, in what form, whether the diet was tested, and whether the claimed benefit is actually supported in the target species. (aafco.org)

What to watch: The next phase will likely center on controlled clinical trials in dogs and cats, better standardization of ingredient characterization and dosing, and closer scrutiny of how companies translate emerging bioactive science into compliant label claims and practical feeding recommendations. If that happens, the category could become more clinically useful, not just more crowded. (frontiersin.org)